Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cytarabine (cytosar-u) (1 trial)
decitabine (dacogen) (1 trial)
Leukemia (Phase 3)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Trials (1 total)
Trial APIs (2 total)